Target intelligence / Profile preview

Porosome-associated protein complex

Molecular classification
Supramolecular complex, Membrane protein complex, Lipoprotein structure
01

Overview

The porosome-associated protein complex, or simply the porosome, is a cup-shaped supramolecular structure located at the cell plasma membrane that serves as the universal machinery for secretion in eukaryotic cells (1.3.1, 1.3.4). It acts as the site where secretory vesicles transiently dock and fuse to release their contents via a highly regulated "kiss-and-run" mechanism, rather than through total vesicle collapse (1.3.5). The complex is composed of approximately 30 to 40 proteins, including SNAREs like syntaxin and SNAP-25, ion channels such as calcium and chloride channels, and cytoskeletal elements like actin and vimentin (1.2.1, 1.3.2). In various diseases, including Alzheimer's, cystic fibrosis, and diabetes, the porosome's structural integrity or function is compromised, leading to defective cellular communication and impaired neurotransmitter or hormone release (1.1.2, 1.4.1). Therapeutic approaches currently in development focus on restoring porosome function through organelle reconstitution, small molecule modulators, and AI-designed peptides that protect the complex from toxic aggregates like beta-amyloid (1.1.1, 1.2.2). These strategies aim to modify disease progression by addressing the root cause of secretory dysfunction at the cellular level (1.2.3, 1.4.2).

Other names
PorosomeSecretory portalFusion pore complexUniversal secretory machineryCup-shaped lipoprotein structure
02

Mechanism of action

Restoration of secretory function, Reconstitution of the porosome complex, Neutralization of toxic beta-amyloid, Modulation of vesicle hydration

03

Biological functions

ExocytosisCellular communicationNeurotransmissionHormone secretionVesicle docking and fusionVesicle hydration and swelling
04

Disease associations

Alzheimer's diseaseCystic fibrosisDiabetes mellitusCancerNeurological disorderParkinson's diseaseHuntington's disease
05

Safety considerations

Systemic toxicity from global secretion modulationOff-target effects on non-target secretory cellsBlood-brain barrier penetration challengesImmunogenicity of reconstituted complexes
06

Interacting drugs

Porosome reconstitution therapy

3 more in the full profile.

07

Biomarkers

Tau proteinPhosphorylated-tau proteinAmylaseInsulinCFTR protein interaction

Beyond the preview

Go deeper on Porosome-associated protein complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porosome-associated protein complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call